Compare Tata India Pharma & Healthcare Fund vs SBI Healthcare Opportunities Fund
Risk
Very High
Very High
Rating
3.0
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.12
1.93
NAV
₹29.72
₹428.69
Fund Started
04 Dec 2015
04 Jun 1999
Fund Size
₹1239.57 Cr
₹3822.73 Cr
Exit Load
Exit load of 0.25% if redeemed within 30 days.
Exit load of 0.50% if redeemed within 15 days
1 Year
7.35%
7.42%
3 Year
23.57%
25.82%
5 Year
15.33%
17.14%
Equity
99.10%
98.53%
Cash
0.90%
1.39%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 9.31% |
Max Healthcare Institute Ltd. | 6.24% |
Abbott India Ltd. | 5.98% |
Divi's Laboratories Ltd. | 5.37% |
Healthcare Global Enterprises Ltd. | 5.14% |
Apollo Hospitals Enterprise Ltd. | 4.97% |
Cipla Ltd. | 4.69% |
Rainbow Children's Medicare Ltd. | 3.75% |
Mankind Pharma Ltd. | 3.38% |
Bayer CropScience Ltd. | 3.34% |
Sun Pharmaceutical Industries Ltd. | 10.02% |
Divi's Laboratories Ltd. | 6.96% |
Apollo Hospitals Enterprise Ltd. | 5.46% |
Max Healthcare Institute Ltd. | 5.01% |
Lupin Ltd. | 4.73% |
Acutaas Chemicals Ltd. | 4.50% |
Torrent Pharmaceuticals Ltd. | 4.14% |
Aether Industries Ltd. | 3.67% |
Biocon Ltd. | 3.60% |
Aster DM Healthcare Ltd. | 3.47% |
Name
-
-
Start Date
-
-
Description
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
04 Dec 2015
04 Jun 1999
